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Mice were exposed to lead from birth by substituting solutions of lead acetate for
the drinking water of their mothers. The suckling mice were thus exposed to lead
through their mother's milk and, at weaning, directly through the drinking water.
Controls received equal concentrations of sodium acetate. No deaths of offspring or
mothers occurred during the first 90 days of exposure. It has been suggested recently
that lead exposure may account for some incidences of behavior disorders in children.
Levels of motor activity of individual offspring were measured from weaning until 70
days of age in specially designed activity cages. Lead-treated mice were more than three
times as active as age-matched or size-matched controls.
Treated and control animals were administered drugs currently used in the treatment
and diagnosis of hyperactivity in children. All control animals responded as expected
to all drugs used in this study. However, lead-treated mice responded paradoxically to
d- and 1-amphetamine, methylphenidate, and phenobarbital. That is, the CNS stimulants
suppressed their hyperactivity while phenobarbital exacerbated the lead-induced hyper-
activity. These findings suggest that lead produces an animal model of hyperactivity
which may have clinical relevance and which may explain some cases of hyperactivity in
children.
Clinical experience has shown a rela-
tionship between lead intoxication and be-
havioral disorders in children (1-4). These
disorders are manifest as irritability, restless-
ness, and aggressiveness, but no experimen-
tal evidence has been previously advanced
to support or deny the clinical experience.
Although animal studies employing high lev-
els of lead exposure have produced signifi-
cant organ damage (5), encephalopathies
(6, 7), and neuromuscular impairment (8,
9), no behavioral dysfunction due to lead
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has been induced. This report presents and
characterizes the results of a study demon-
strating a significant behavior disorder in
mice resulting from chronic ingestion of lead.
Methods
The animal model of chronic lead poison-
ing developed in this study follows a design
similar to that first devised by Pentschew
and Garro (10) and Rosenblum and John-
son (6). The route of exposure in these
studies, and the present one, is indirect. Lead
is administered to the mother and through
her to nursing offspring which are the sub-
ject of study. In this research, lead acetate
was dissolved in boiled distilled water and
May 1974 227supplied for drinking water to pregnant CD-
1 mice (Charles River Lab) upon parturi-
tion. Three concentrations of lead were
used: 2, 5, and 10 mg/ml. Controls received
equal concentrations of sodium acetate. Lit-
ters were normalized to six animals 48 hr
after birth. Upon weaning, the offspring
were separated by sex and housed by litter.
At that time, six litters of mice (36 ani-
mals) from mothers on lead solutions, (two
from each treatment level) were placed on
tap water, while the others were continued
on the same solutions which had been sup-
plied to their mothers. Growth and develop-
ment of the offspring were monitored from
birth to 60 days of age.
Between 30 and 150 days of age, the off-
spring were individually tested for levels of
motor activity. Motor activity was measured
by placing a grid arrangement of 2 in square
electrosensitive plates under a cage similar
to those in which the animals were housed
(9). Basically, the unit of activity meas-
ured was the crossing by the mouse from
active to ground square. In all experiments
offspring from control and treated mothers
were simultaneously tested. In the first 21
experiments, animals were measured for ac-
tivity for 3 hr on four consecutive days. Af-
ter having established a pattern of activity,
subsequent experiments were run for 3 hr
consecutively on only one day.
The data to be presented were obtained
on over 150 animals from over 30 litters
developed at four different times during the
calendar year.
Results
Growth and development were significantly
affected in offspring of mothers given
lead solutions to drink. A dose-related depres-
sion in growth (Fig. 1) from day 5 through
day 60 was observed in mice treated with 2,
5, and 10 mg/ml lead acetate. Sauerhoff anrd
Michaelson (11) reported that this may be
due to decreased food intake by the mother.
However, in this study we observed no
weight loss by the mothers during the suck-
ling period. At weaning, 12 animals from
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FIGuRE 1. Effects of lead on growth of mice. Points
are means for 3040 animals. Differences in
weight for all doses and controls are significant
from day 20 to day 60 (P<0.01) except for con-
trols and 2 mg/ml animals on day 40. Data of
Silbergeld and Goldberg (9).
each treatment level were placed on tap wa-
ter. These offspring reached near control
weights within 10 days after removal of
lead. Offspring continued on the same lead
solutions as supplied to their mothers prior
to weaning remained significantly smaller
than coetaneous controls. Development land-
marks were greatly retarded in mice receiv-
ing lead (Table 1). Eye opening, full inci-
dence of body hair, coordinated walking, and
weaning were delayed by as much as 8 days
in the lead-treated offspring as compared
to either controls or strain data.
At 30 days of age, offspring maintained
after weaning on solutions of 5 and 10 mg/
ml lead acetate began to show motor deficits
and the suggestion of behavioral disorders
due to lead. Some of these animals developed
noticeable peripheral ataxia of their hind
limbs and a characteristic splayed gait (Fig.
2). Observation of these animals also indi-
cated a heightened reactivity and an in-
creased frequency of fighting as determined
by the incidence of bites on littermate males
housed together.
Ingestion of lead significantly increased
levels of motor activity in mice (Fig. 3).
This figure shows results of three consecu-
tive days of activity testing in 21 mice (40-
60 days old) maintained before and after
weaning on 10 mg/ml lead acetate, as com-
Environmental Health Perspectives 228FIGURE 2. Peripheral neuromyopathy of lead. At top
of photograph is a 40-day old mouse maintained
before and after weaning on 10 mg/ml lead ace-
tate. Lower animal is coetaneous control.
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FIGURE 3. Effects of lead on motor activity (counts
per hour) of 40- to 60-day-old mice given 10 mg/ml
lead acetate before and after weaning. Results are
for 21 treated and 21 control mice tested on three
consecutive days. Differences between controls and
treated are significant at P<0.001. Data of Silber-
geld and Goldberg (9).
pared to 21 coetaneous controls. During the
first hour of activity measurement of day 1,
the treated mice had activity levels above
1200 counts/hr. Control mice had motor ac-
tivity levels less than 600 counts/hr during
the same measurement period. Both groups
habituated comparably to the measurement
conditions, as demonstrated by a sharp de-
crease in motor activity over the second hour
of measurement. Nevertheless, lead-treated
animals remained significantly more active
than controls during the second hour and,
indeed- for the rest of the measurement pe-
riods over which they were tested. In fact,
treated mice were slightly more than three
times as active as controls.
Increases in motor activity were seen in
mice treated before and after weaning with
2, 5, and 10 mg/ml lead acetate. There were
no differences in the degree of heightened
motor activity of 40 to 60 day-old mice
treated with any concentration of lead in
this range (Table 2).
To see whether or not the maturity of the
Table 1. Developmental landmarks in lead-treated
and control mice.
Day of occurrence
Strain Controls Lead
Landmark Data (10 mg/ml)
Eye opening 14 13 17
Full incidence 16-17 16 20
of hair
Coordinated 17-18 18 25
walking
Weaning 21 22 30
*Information on CD-1 mice supplied by Charles
River Laboratories. Data of Silbergeld and Goldberg
(12).
Table 2. Motor activity levels in mice treated with
2, 5, and 10 mg/ml lead acetate and controls.
Concentration of
lead acetate in Motor activity,
drinking water, counts/hr
mg/mi Number (for hour 2, day 1)"
2 6 845:±126
5 20 942± 80
10 21 825± 40
0 21 310± 25
Means ± standard errors of the mean. Data of
Silbergeld and Goldberg (12).
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229offspring influenced activity, a series of ex-
periments was performed on animals be-
tween the ages of 30 to 150 days. Offspring
receiving 5 mg/ml lead acetate were tested
for activity against coetaneous controls. All
lead-treated animals were at least three
times as active (Fig. 4). Further, the high-
est level of activity of either group was at
30 days. However, the level of activity of 30-
day-old controls (556 ±75 counts/hr) was
not as great as that in the lead-treated mice
at any time period.
The drugs selected for study were chosen
for their relevance in the treatment of what
has been called minimal brain dysfunction
hyperactivity in children (13, 14). All drugs
were dissolved in distilled water and admin-
istered IP. In control mice, d- and i-amphe-
tamine at 10 mg/kg produced significant in-
creases in motor activity accompanied by
stereotypic behavior such as chewing, gnaw-
ing, and drooling. Methylphenidate (40 mg/
kg) also increased activity of control mice.
The sedative drugs phenobarbital at 20 mg/
kg and chloral hydrate (100 mg/kg) de-
creased motor activity as expected (Fig. 5).
In lead-induced hyperactive mice, para-
doxical responses to CNS stimulants and the
barbiturate phenobarbital were observed
(Fig. 5). In these mice, d-amphetamine sig-
nificantly suppressed motor activity to about
1/10 of the predrug baseline. Further, there
were no observable signs of stereotypic be-
havior. Both methylphenidate and i-amphe-
tamine also decreased the activity of lead-
treated hyperactive mice, although to a
lesser degree than c-amphetamine at the
doses used. Phenobarbital produced a very
marked increase in the level of activity of
these mice. At 20 mg/kg, phenobarbital
stimulated their already high levels of activi-
ty to 2000 counts/hr, the highest seem with
any group on any treatment. Chloral hydrate
depressed activity to the same degree in
treated and control mice with the onset and
duration of complete sedation the same in
both groups. It is interesting to note that
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FIGURE 4. Effects of lead on motor activity (counts/
hr) of 30- to 150-day-old mice given 5 mg/ml lead
acetate before and after weaning. Results are for
the second hour of measurement with each point
representing the mean S. E. M. for 5-16 ani-
mals. Differences between controls (solid line) and
treated are significant at P<O.0O1.
FIGURE 5. Effects of drugs on motor activity (counts/
hr) in control and treated mice. Open bars repre-
sent predrug baselines in both groups. Results are
expressed as means S.E.M. of at least seven
animals. Differences in response to all drugs be-
tween control and treated mice were significant at
P<0.0O1. Data of Silbergeld and Goldberg (15).
Environmental Health Perspectives
1750
1500
1250
1000
P 750
500
250
I
I
I
T
I
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childhood hyperactivity (13).
Figure 6 shows the results of a dose-
response study for c-amphetamine on con-
trols and treated mice. In control animals,
d-amphetamine produced a dose-related in-
crease in motor activity with stereotypic
behavior apparent at the higher doses. In the
lead-induced hyperactive mice, d-ampheta-
mine at doses of 2 and 5 mg/kg slightly in-
creased levels ofmotor activity. At 10 mg/kg,
d-amphetamine completely suppressed motor
activity with no observable signs of stereo-
typic behavior.
Discussion
These experiments demonstrate that
chronic ingestion of lead, supplied through
the drinking water, can produce a significant
behavioral disorder in mice, i.e., a signifi-
cantly increased level of motor activity. This
hyperactivity was seen in animals exposed to
lead from birth and persisted for at least
150 days. All animals tested were chosen
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FIGURE 6. Motor activity response, (counts/hr) to d-
amphetamine in control and treated mice. Each
point is the mean of seven animals. Data of Silber-
geld and Goldberg.
for lack of any overt signs of neuromuscular
damage, although they were significantly
smaller than controls of the same age.
Lead-induced hyperactivity was not ap-
parently dose-related, at leastnot inthe range
of doses used in these experiments. This
would suggest that increases in motor activ-
ity may be an early symptom of lead poison-
ing associated with low level intoxication.
Increases in the amount of lead to which an-
imals are exposed do not change this symp-
tom but rather may induce other sequelae
such as peripheral ataxia, encephalopathies,
and death. Aniamls treated with 10 mg/ml
lead acetate did in fact begin to die by day
90.
The response to c-amphetamine in lead-
induced hyperactivity is similar to that ob-
served in childhood hyperactivity. In the lat-
ter, it has been observed that the dosage of
amphetamine must be increased until an ef-
fective dose is reached. In these lead-
induced hyperactive mice a dramatic de-
crease in motor activity is obtained at 10
mg/kg. The resulting level of activity after
d-amphetamine is lower than in control ani-
mals in the absence of any therapy.
In the drug studies reported, all control
animals responded to all drugs in the pre-
dicted manner. However, the lead treated
mice responded paradoxically to central ner-
vous system stimulants in an analogous man-
ner to hyperactive children.
Epidemiological evidence has recently
been presented by David et al. (4) for the co-
incidence of hyperactivity with a history of
lead exposure in children. Correlations be-
tween lead poisoning and the widespread
childhood behavior disorder, hyperactivity or
hyperkinesia, are most provocative, since the
biochemical lesions involved in either lead
poisoning or hyperactivity are not known.
The importance of demonstrating behavioral
disorder resulting from lead ingestion is
therefore, threefold: (1) the development in
an animal model of a behavioral aspect of
lead poisoning permits further investigations
into neurochemical mechanisms and possible
therapies; (2) the results of this study sup-
port a causal relationship between chronic,
May 1974 a2elsublethal lead exposure and a serious behav-
ioral disorder; and (3) the lead-induced be-
havioral disorder appears to have significant
parallels with the pharmacology of minimal
brain dysfunction hyperactivity in children
which may allow use of this model in the
further study and testing of therapeutic
drugs of this disease.
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